The Study of the Impact of Disclosing Imaging Study Information to Trial Participants

CompletedOBSERVATIONAL
Enrollment

800

Participants

Timeline

Start Date

July 31, 2006

Primary Completion Date

June 27, 2008

Study Completion Date

August 31, 2008

Conditions
Parkinsonian SyndromeParkinson
Interventions
BEHAVIORAL

A series of questionnaires

Research participants who previously underwent ß-CIT imaging will be contacted by the staff at IND to enquire whether they would like to receive their ß-CIT scan data. After signing a Research Participant Information and Consent Form, all research participants will be asked to complete a questionnaire prior to receipt of their imaging data. Those research participants requesting imaging data will be sent their data by IND and may review their data with IND (by phone) and/ or with their study investigator. All research participants will be asked to respond to a second questionnaire after receiving their imaging data and to a third study questionnaire approximately six weeks following receipt of their imaging data.

Trial Locations (1)

06510

Institute for Neurodegenerative Disorders, New Haven

All Listed Sponsors
lead

Institute for Neurodegenerative Disorders

OTHER

NCT00354003 - The Study of the Impact of Disclosing Imaging Study Information to Trial Participants | Biotech Hunter | Biotech Hunter